Changeflow GovPing Pharma & Drug Safety USPTO Patent Grant: Process for Ethyleneamines ...
Routine Rule Added Final

USPTO Patent Grant: Process for Ethyleneamines and Ethanolamines Manufacture

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has granted patent US12583827B2 to BASF SE for a new process to manufacture ethyleneamines and ethanolamines. The patent details a two-step process involving the conversion of glycolaldehyde derivatives and an aminating agent, followed by hydrogenation.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO Patent Grant US12583827B2, assigned to BASF SE, details a novel process for manufacturing ethyleneamines and ethanolamines. The patent describes a two-step method: first, converting a glycolaldehyde derivative with an aminating agent in either gas or liquid phase; second, hydrogenating the resulting reaction products in the presence of a catalyst. This grant provides exclusive rights for this specific chemical manufacturing process.

While this is a patent grant and not a regulatory rule imposing direct compliance obligations on other entities, companies involved in the production of ethyleneamines and ethanolamines should be aware of this granted patent. Competitors may need to ensure their manufacturing processes do not infringe on the claims of this patent, potentially requiring review of their own chemical synthesis methods and seeking alternative, non-infringing processes if necessary.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Products obtained by the conversion of glycolaldehyde derivatives and aminating agents and their conversion to ethyleneamines and ethanolamines

Grant US12583827B2 Kind: B2 Mar 24, 2026

Assignee

BASF SE

Inventors

Martin Ernst, Tatjana Huber, Johann-Peter Melder, Stephanie Jaegli, Thomas Krug

Abstract

A process for the manufacture of ethyleneamines and ethanolamines, comprising the steps of (i) converting a glycolaldehyde derivative of formula (II), in which R2, R3 are—the same or different—hydrogen, alkyl, such as C1-6-alkyl, or cycloalkyl such as Cs-e-cycloalkyl; and an animating agent of formula (III); in which R1 is hydrogen (H), alkyl, such as C1-6-alkyl, or cycloalkyl such as C3-6-cycloalkyl, in the gas or liquid phase; (ii) feeding the reaction products obtained in step (i) into a hydrogenation reactor, where the reaction products are converted with hydrogen in the presence of a hydrogenation catalyst.

CPC Classifications

C07D 251/04

Filing Date

2020-06-02

Application No.

17617205

Claims

18

View original document →

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12583827B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Chemical Synthesis Process Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Topics
Chemical Manufacturing Process Patents

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!